Ongoing quality problems at injectables plant hurt Hospira in Q3
Hospira says ‘quality actions’ taken to fix problems at key injectable drug manufacturing plant in US reduced its third quarter earnings.
Archives for October 18, 2011
New Hamner - PBM venture says its toxicity testing could save billions in drug discovery
The Hamner Institutes for Health Sciences and private equity firm PBM Capital Group (PBM) have thrashed out a venture for toxicity testing which they say could save the drug discovery industry billions.
Icon extends medical imaging capabilities through vRad partnership
Icon has extended its medical imaging division through a new partnership agreement with Virtual Radiologic (vRad).
PPD shares ‘limited’ confidential info with new potential buyer
Under offer CRO PPD has signed a confidentiality agreement with another potential buyer according to an SEC filing submitted last week.
JSS & Venn partner to offer transatlantic clinical services
JSS Medical Research has bought Canadian assets from Venn Life Sciences as part of a joint-venture spanning North America and Europe.
GSK hit with warning letter as FDA finds faults with UK site
The FDA has sent GSK a GMP warning letter after finding failings in steps to prevent microbiological contamination at a UK site.
RFID data collection drives packaging productivity gains
Gathering data with RFID can ensure reliable pharma packaging supply by improving delivery date predictions, researchers claim.
Canadian drug shortage plan fails to tackle problems; analyst
Canadian pharma manufacturers’ plan to stop drug shortages by sharing information fails to tackle underlying concerns, an analyst said.